Unchanged renal haemodynamics following high dose ascorbic acid administration in normoalbuminuric IDDM patients

References

• Hanum S. Clinical studies of 195 cases of retinal changes in diabetics. Thesis, Einar Munksgaard, Copenhagen 1938
   Google Scholar
• Aron E, Breteau M, Dupin M, Chevallier M-T. L'hypoascorbémie du diabétique. Quest Médical 1977; 18: 1243–8
   Google Scholar
• Som S, Basu S, Mukherjee D, Deb S, Choudhury P R, Mukherjee S, et al. Ascorbic acid metabolism in diabetes mellitus. Metabolism 1981; 30: 572–7
   PubMed Web of Science ®Google Scholar
• Ali S MK, Chakraborty S K. Role of plasma ascorbate in diabetic microangiopathy. Bangladesh Med Res Counc Bull 1989; 15: 47–59
   Google Scholar
• Sinclair A J, Girling A J, Gray L, Le Guen C, Lunec J, Barnett A H. Disturbed handling of ascorbic acid in diabetic patients with and without microangiopathy during high dose ascorbate supplementation. Diabetologia 1991; 34: 171–5
   Google Scholar
• Tilton R G, Chang K, Pugliese G, Eades D M, Province M A, Sherman W R, et al. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors. Diabetes 1989; 37: 1258–70
   Google Scholar
• Vinson J A, Staretz M E, Bose P, Kassm H M, Basalyga B S. In vitro, in vivo reduction of erythrocyte sorbitol by ascorbic acid. Diabetes 1989; 38: 1036–41
   PubMed Web of Science ®Google Scholar
• Yue D K, McLennan S, Fisher E, Heffernan S, Capogreco C, Ross G R, et al. Ascorbic acid metabolism and polyol pathway in diabetes. Diabetes 1989; 38: 257–61
   PubMed Web of Science ®Google Scholar
• McLennan S, Yue D K, Fisher E, Capogreco C, Heffernan S, Ross G R, et al. Deficiency of ascorbic acid in experimental diabetes. Relationship with collagen and polyol pathway abnormalities. Diabetes 1988; 37: 359–61
   Google Scholar
• Mogensen C E. Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy. Scand J Clin Lab Invest 1986; 46: 201–6
   PubMed Web of Science ®Google Scholar
• Mau Pedersen M, Christiansen J S, Mogensen C E. Reduction of glomerular hyperfiltration in normoalbuminuric IDDM patients by 6 months of aldose reductase inhibition. Diabetes 1991; 40: 527–31
   Google Scholar
• Mogensen C E. Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus. Scand J Clin Lab Invest 1971; 28: 91–100
   PubMed Web of Science ®Google Scholar
• Christensen C K, Ørskov C. Rapid screening PEG radioimmunoassay for quantification of pathological microalbuminuria. Diabetic Nephropathy 1984; 3: 92–4
   Google Scholar
• Jeppsson J O, Jerntorp P, Sundkvist G, Englund H, Nylund V. Measurement of haemoglobin Alc by a new liquid-chromatographic assay: methodology, clinical utility, and relation to glucose tolerance evaluated. Clin Chem 1986; 32: 1867–72
   PubMed Web of Science ®Google Scholar
• Mann G V. Hypothesis: the role of vitamin C in diabetic angiopathy. Perspec Biol Med 1974; 17: 210–7
   PubMed Web of Science ®Google Scholar
• Kinalska I, Gosiewska A, Karna E, Borejszo I. Plasma ascorbic acid/AA/concentration in type I and II diabetic patients with and without microangiopathy. Diabetes 1991; 40(Suppl 1)474A
   Google Scholar
• Zebrowski E J, Bhatnager P K. Urinary excretion pattern of ascorbic acid in streptozotocin diabetic and insulin treated rats. Pharmacol Res Commun 1979; 11: 95–103
   Google Scholar
• Rudberg S, Persson B, Dahlquist G. Increased glomerular filtration rate as a predictor of diabetic nephropathy—An 8-year prospective study. Kidney Int 1992; 41: 822–8
   PubMed Web of Science ®Google Scholar
• Goldfarb S, Simmons D A, Kern E FO. Amelioration of glomerular hyperfiltration in acute experimental diabetes mellitus by dietary myoinositol supplementation and aldose reductase inhibition. Trans Assoc Am Physicians 1986; 99: 67–72
   Google Scholar
• Bank N, Mower P, Aynedjian H S, Wilkes B M, Silverman S. Sorbinil prevents glomerular hyperperfusion in diabetic rats. Am J Physiol 1989; 256: F1000–6
   Google Scholar
• Bank N, Coco M, Aynedjian H S. Galactose feeding causes glomerular hyperfiltration: prevention by aldose reductase inhibition. Am J Physiol 1989; 256: F994–9
   Google Scholar
• Daniels B S, Hostetter T H. Aldose reductase inhibition and glomerular abnormalities in diabetic rats. Diabetes 1989; 38: 981–6
   PubMed Web of Science ®Google Scholar
• Malone J I, Leavengood H, Peterson M J, O'Brien M M, Page M G, Aldinger C E. Red blood cell sorbitol as an indicator of polyol pathway activity. Inhibition by sorbinil in insulin-dependent diabetic subjects. Diabetes 1984; 33: 45–9
   Google Scholar
• Mann G V, Newton P. The membrane transport of ascorbic acid. Ann NY Acad Sci 1975; 258: 243–52
   PubMed Web of Science ®Google Scholar
• Bigley R, Wirth M, Layman D, Riddle M, Stankova L. Interaction between glucose and dehydroascorbate transport in human neutrophils and fibroblasts. Diabetes 1983; 32: 545–8
   PubMed Web of Science ®Google Scholar
• Kapeghian J C, Verlangieri A J. The effects of glucose on ascorbic acid uptake in heart endothelial cells: possible pathogenesis of diabetic angiopathies. Life Sciences 1984; 34: 577–84
   Google Scholar
• Khatami M, Li W, Rockey J H. Kinetics of ascorbate transport by cultured retinal capillary pericytes. Invest Ophthalmol Vis Sci 1986; 27: 1665–71
   PubMed Web of Science ®Google Scholar
• Chen M S, Hutchinson M L, Pecoraro R E, Lee W YL, Labbé R F. Hyperglycemia-induced intracellular depletion of ascorbic acid in human mononuclear leukocytes. Diabetes 1983; 32: 1078–81
   PubMed Web of Science ®Google Scholar
• Scarlett J A, Zeidler A, Rochman H, Rubenstein A. Acute effect of ascorbic acid infusion on carbohydrate tolerance. Am J Clin Nutr 1976; 29: 1339–42
   PubMedGoogle Scholar
• Stankova L, Riddle M, Larned J, Burry K, Menashe D, Hart J, et al. Plasma ascorbate concentrations and blood cell dehydroascorbate transport in patients with diabetes mellitus. Metabolism 1984; 33: 347–53
   PubMed Web of Science ®Google Scholar
• Bigley R, Stankova L, Roos D, Loos J. Glutathione-dependent dehydroascorbate reduction: a determinant of dehydroascorbate uptake by human polymorphonuclear leukocytes. Enzyme 1980; 25: 200–4
   PubMedGoogle Scholar
• Bigley R, Riddle M, Layman D, Stankova L. Human cell dehydroascorbate reductase kinetic and functional properties. Biochim Biophys Acta 1981; 659: 15–22
   PubMedGoogle Scholar
• Stankova L, Rigas D A, Bigley R H. Dehydroascorbate uptake and reduction by human blood neutrophils, erythrocytes, and lymphocytes. Ann NY Acad Sci 1975; 258: 238–42
   PubMed Web of Science ®Google Scholar
• Verlangieri A J, Sestito J. Effect of insulin on ascorbic acid uptake by heart endothelial cells: possible relationship to retinal atherogenesis. Life Sci 1981; 29: 5–9
   Web of Science ®Google Scholar
• Burns J J. Missing step in man, monkey and guinea pig required for the biosynthesis of L-ascorbic acid. Nature 1957; 180: 553
   PubMedGoogle Scholar